Table 4. Overall antibiotics resistance/susceptibility.
| Antibiotics | Intermediate | Resistant | Sensitive |
| Amikacin | 1(0.8%) | 15(12%) | 109(87.2%) |
| Gentamicin | 2(1.6%) | 37(29.6%) | 86(68.8%) |
| Amoxicillin-clavulanic acid | 10(8%) | 85(68%) | 30(24%) |
| Aztreonam | 0(0%) | 81(64.8%) | 44(35.2%) |
| Cefotaxime | 0(0%) | 86(68.8%) | 39(31.2%) |
| Ceftazidime | 0(0%) | 83(66.4%) | 42(33.6%) |
| Ciprofloxacin | 8(6.4%) | 90(72%) | 27(21.6%) |
| Norfloxacin | 0(0%) | 86(68.8%) | 39(31.2%) |
| Levofloxacin | 2(1.6%) | 75(60%) | 48(38.4%) |
| Nitrofurantoin | 2(1.6%) | 38(30.4%) | 85(68%) |
| Ertapenem | 1(0.8%) | 18(14.4%) | 106(84.8%) |
| Imipenem | 1(0.8%) | 7(5.6%) | 117(93.6%) |
| Meropenem | 0(0%) | 6(4.8%) | 119(95.2%) |
| Cefoperazone-sulbactam | 11(8.8%) | 17(13.6%) | 97(77.6%) |
| Piperacillin-tazobactam | 11(8.8%) | 17(13.6%) | 97(77.6%) |
| Polymyxin-B | 0(0%) | 0(0%) | 125(100%) |
| Colistin | 0(0%) | 0(0%) | 125(100%) |
| Tigecycline | 0(0%) | 0(0%) | 125(100%) |
| Fosfomycin | 0(0%) | 0(0%) | 125(100%) |
| Doxycycline | 0(0%) | 41(32.8%) | 84(67.2%) |
| Cotrimoxazole | 0(0%) | 63(50.4%) | 62(49.6%) |